Zhejiang Tianyu Pharmaceutical (300702.SZ)Pregabalin Capsules Obtained Drug Registration Certificate
Tianyu Group (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode...
Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Prugabalin Capsules.
The announcement stated that Prugabalin Capsules are used to treat postherpetic neuralgia and fibromyalgia, a medication for postherpetic neuralgia.
Related Articles
Berkshire (BRK.A.US/BRK.B.US) Q3 operating profit falls 5.8%: buybacks highest of the year, cash rises to $377.4 billion
US IPO Analysis | Mengxun Machinery (PNIG.US), with Rapidly Growing Performance, Seeks Change to Survive as It Aims to Transform from a Trader into a Solution Provider
"Profit resilience" becomes the key phrase in Q3 earnings reports; how much further can Beijing Chunlizhengda Medical Instruments (01858) go after four consecutive trading days of gains?
Berkshire (BRK.A.US/BRK.B.US) Q3 operating profit falls 5.8%: buybacks highest of the year, cash rises to $377.4 billion
US IPO Analysis | Mengxun Machinery (PNIG.US), with Rapidly Growing Performance, Seeks Change to Survive as It Aims to Transform from a Trader into a Solution Provider
"Profit resilience" becomes the key phrase in Q3 earnings reports; how much further can Beijing Chunlizhengda Medical Instruments (01858) go after four consecutive trading days of gains?
